Biofrontera (BFRI)
NASDAQ:BFRI
Total Valuation
Biofrontera has a market cap or net worth of $9.42M. The enterprise value is $10.50M.
Market Cap$9.42M
Enterprise Value$10.50M
Share Statistics
Biofrontera has 11,648,323 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,648,323
Owned by Insiders3.99%
Owned by Institutions17.77%
Financial Efficiency
Biofrontera’s return on equity (ROE) is -1.01 and return on invested capital (ROIC) is -66.75%.
Return on Equity (ROE)-1.01
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-66.75%
Return on Capital Employed (ROCE)-0.68
Revenue Per Employee453.32K
Profits Per Employee-114.52K
Employee Count92
Asset Turnover1.46
Inventory Turnover7.09
Valuation Ratios
The current PE Ratio of Biofrontera is ―. Biofrontera’s PEG ratio is 0.00813.
PE Ratio―
PS Ratio0.14
PB Ratio0.55
Price to Fair Value0.55
Price to FCF-0.43
Price to Operating Cash Flow-0.80
PEG Ratio0.00813
Income Statement
In the last 12 months, Biofrontera had revenue of 41.70M and earned -10.54M in profits. Earnings per share was -1.04.
Revenue41.70M
Gross Profit31.59M
Operating Income-11.35M
Pretax Income-10.51M
Net Income-10.54M
EBITDA-10.48M
Earnings Per Share (EPS)-1.04
Cash Flow
In the last 12 months, operating cash flow was -13.36M and capital expenditures -2.00K, giving a free cash flow of -13.36M billion.
Operating Cash Flow-13.36M
Free Cash Flow-13.36M
Free Cash Flow per Share-1.15
Dividends & Yields
Biofrontera pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.56
52-Week Price Change14.86%
50-Day Moving Average0.88
200-Day Moving Average0.88
Relative Strength Index (RSI)59.56
Average Volume (3m)120.49K
Important Dates
Biofrontera upcoming earnings date is May 8, 2026, Before Open (Confirmed).
Last Earnings DateMar 19, 2026
Next Earnings DateMay 8, 2026
Ex-Dividend Date―
Financial Position
Biofrontera as a current ratio of 1.52, with Debt / Equity ratio of 58.79%
Current Ratio1.52
Quick Ratio1.40
Debt to Market Cap1.06
Net Debt to EBITDA0.02
Interest Coverage Ratio-25.11
Taxes
In the past 12 months, Biofrontera has paid 25.00K in taxes.
Income Tax25.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Biofrontera EV to EBITDA ratio is -0.53, with an EV/FCF ratio of -0.42.
EV to Sales0.13
EV to EBITDA-0.53
EV to Free Cash Flow-0.42
EV to Operating Cash Flow-0.42
Balance Sheet
Biofrontera has $6.39M in cash and marketable securities with $6.16M in debt, giving a net cash position of $231.00K billion.
Cash & Marketable Securities$6.39M
Total Debt$6.16M
Net Cash$231.00K
Net Cash Per Share$0.02
Tangible Book Value Per Share$0.77
Margins
Gross margin is 75.76%, with operating margin of -27.21%, and net profit margin of -25.26%.
Gross Margin75.76%
Operating Margin-27.21%
Pretax Margin-25.20%
Net Profit Margin-25.26%
EBITDA Margin-25.13%
EBIT Margin-27.21%
Analyst Forecast
The average price target for Biofrontera is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$9.00
Price Target Upside1116.22% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast5.11%
EPS Growth Forecast19.78%